Upload a photo. Answer 5 questions.
See what you'd look like after GLP-1 therapy.
Upload a photo and see a realistic projection of what you'd look like after GLP-1 weight loss therapy. MeOnGLP uses AI image generation and clinical trial data from the STEP program to create personalized before-and-after body transformations.
Upload a full-body photo. Answer five quick questions about your height, weight, age, sex, and goals. Our AI generates a photorealistic projection of you at your target weight based on published semaglutide clinical trial outcomes.
Every projection is grounded in peer-reviewed research from the STEP 1-5 clinical trials, the SELECT cardiovascular outcomes trial, and the SURMOUNT-1 tirzepatide trial. Weight loss projections range from 5-24% of body weight depending on your starting BMI, matching the ranges observed in these landmark studies of semaglutide 2.4mg and tirzepatide.
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have shown significant weight loss results in clinical trials. MeOnGLP helps you visualize what those results could look like for your specific body.
GLP-1 (glucagon-like peptide-1) receptor agonists are medications originally developed for type 2 diabetes that have shown remarkable weight loss effects. Semaglutide and tirzepatide are the most common, available under brand names like Ozempic, Wegovy, Mounjaro, and Zepbound.
Clinical trials show average weight loss of 15-22% of body weight over 12-16 months on semaglutide 2.4mg. Results vary by individual, starting weight, and adherence. Tirzepatide has shown even higher averages of up to 22.5% in the SURMOUNT-1 trial.
Yes. MeOnGLP is completely free to use. We earn revenue through affiliate partnerships with licensed telehealth providers.
No. Your photo is processed in real-time and never stored on our servers. It is sent to OpenAI's image API for the transformation and discarded after your session.